provider image
Welcome! You’re in GoodRx for healthcare professionals. Now, you’ll enjoy a streamlined experience created specifically for healthcare professionals.
Skip to main content

Farydak

panobinostat
Used for Multiple Myeloma
Used for Multiple Myeloma

Farydak (panobinostat) is a medication that's taken by mouth for the treatment of multiple myeloma (a type of bone marrow cancer). It was initially approved to be a part of a treatment that also included Velcade (bortezomib) and dexamethasone (Taperdex). It was only to be used by certain people for whom previous chemotherapy treatments didn't work well. Farydak (panobinostat) has been discontinued by the manufacturer and is no longer available in the United States.

Last reviewed on July 21, 2022
basics-icon

What is Farydak (panobinostat)?

What is Farydak (panobinostat) used for?

  • Multiple myeloma

How Farydak (panobinostat) works

Are you looking for information on Zolinza (vorinostat) or Beleodaq (belinostat) instead?

Drug Facts

Common BrandsFarydak (brand no longer available)
Drug ClassHistone deacetylase inhibitor
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityDiscontinued
faqs

Frequently asked questions about Farydak (panobinostat)

What is Farydak (panobinostat)?
Farydak (panobinostat) is a medication used for the treatment of multiple myeloma. This medication is a histone deacetylase (HDAC) inhibitor. It works by acting on the genetic material of the cancer cells and preventing the cancer cells from multiplying and making the proteins they need to grow and survive. Farydak (panobinostat) works by targeting multiple myeloma cancer cells and stopping their growth.
Is Farydak (panobinostat) still available?
No, Farydak (panobinostat) has been discontinued and is no longer available in the United States. If this medication is necessary as part of your chemotherapy regimen, your provider can apply for access to Farydak (panobinostat) through Project Facilitate, which is a FDA program that allows certain people with life-threatening conditions to try medications that aren't on the market.
Why was Farydak (panobinostat) discontinued?
Farydak (panobinostat) was approved by the FDA through its Accelerated Approval Program in 2015. But the manufacturer (Secura Bio) voluntarily discontinued this medication in 2021. It was taken off the market because the manufacturer couldn't complete all the clinical studies it needed to do under the Accelerated Approval Program. Therefore, the manufacturer wasn't able to confirm beneficial health outcomes after this medication was approved (in this case, whether Farydak (panobinostat) slows down cancer growth and helps people with multiple myeloma live longer).
What other medications can I use instead of Farydak (panobinostat)?
There are many different factors that a provider must consider in choosing the right multiple myeloma treatment for you, such as your medical history, age, how well you'll tolerate chemotherapy, how far your cancer has progressed, and whether you’re eligible for a stem cell transplant. Typically, chemotherapy regimens for multiple myeloma include 3 or 4 medications. Several alternative medications to Farydak (panobinostat) are available, including lenalidomide (Revlimid) and cyclophosphamide (Cytoxan), which are taken by mouth. These medications are often used in combination with other chemotherapy medications to destroy or attack cancer cells. Keep in mind that there are currently no medications that can cure multiple myeloma, but treatment can help slow cancer cell growth. Talk with your provider to determine which multiple myeloma treatment is best for you.
GoodRxEducationalIcon

How to save using GoodRx

Compare Prices
1. Compare PricesSpecify your dosage and quantity to find out exactly how much you can save.
Select your free coupon
2. Select your free couponYou can use the displayed coupon, or compare prices at other pharmacies near you.
Show coupon to your pharmacist
3. Show coupon to your pharmacistPresent your printed or electronic coupon when you pick up your prescription.
Get free couponLearn more
alternatives

What are alternatives to Farydak (panobinostat)?

There are a number of medications that your doctor can prescribe in place of Farydak (panobinostat). Compare a few possible alternatives below.
Farydak (panobinostat)
Used for:
  • Multiple myeloma

Used for:
$83.51 Lowest GoodRx priceView Prices

Get savings updates for Farydak (panobinostat)

Receive price alerts, news, and other messages from GoodRx about Farydak (panobinostat) and other healthcare topics and relevant savings offers.

By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.

Compare other Multiple Myeloma drugs

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.